High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study
2012 · BMC Ophthalmology · 32 citations
https://doi.org/10.1186/1471-2415-12-20
P
Pichai Jirarattanasopa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
562
Citations
9
h-index
8
i10-index
Pichai Jirarattanasopa is an academic researcher from Prince of Songkla University. The author has contributed to research in topics: Retinal Diseases and Treatments & Retinal Imaging and Analysis & Retinal and Optic Conditions. The author has an h-index of 9, co-authored 25 publications.
ORCID: 0000-0003-0584-5101Papers by this author
worksOne-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
2021 · BMC Ophthalmology · 10 citations
https://doi.org/10.1186/s12886-020-01796-0
A distinct APC pathogenic germline variant identified in a southern Thai family with familial adenomatous polyposis
2021 · BMC Medical Genomics · 6 citations
https://doi.org/10.1186/s12920-021-00933-y
PNEUMATIC DISPLACEMENT AND INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR, WITH OR WITHOUT INTRAVITREAL TISSUE PLASMINOGEN ACTIVATOR, INJECTION FOR SUBMACULAR HEMORRHAGE
2024 · Retina · 2 citations
https://doi.org/10.1097/iae.0000000000004337
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat